Positron emission tomography/computed tomography: diagnostic accuracy in lymphoma

Area of Science:

• Nuclear Medicine
• Radiology
• Oncology

Background:

• Accurate initial staging of non-Hodgkin lymphoma (NHL) and Hodgkin lymphoma (HL) is crucial for effective treatment selection.
• Computed tomography (CT) is the standard but relies on anatomical criteria.
• Positron emission tomography (PET) offers functional data but needs anatomical correlation for precise localization.

Purpose of the Study:

• To prospectively compare the accuracy of combined PET/CT with CT and PET alone for initial lymphoma staging.
• To evaluate the impact of PET/CT on disease staging and subsequent treatment strategy.

Main Methods:

• Prospective evaluation of 47 newly diagnosed lymphoma patients.
• Comparison of imaging data from CT, PET alone, and combined PET/CT.
• Analysis of nodal and extranodal disease detection and staging accuracy.

Main Results:

• PET/CT demonstrated superiority over CT and PET alone in nodal evaluation and extranodal disease detection.
• Disease stage was increased in 11 of 47 patients (10 NHL, 1 HL) based on PET/CT findings (McNemar test P = 0.012).
• A revised treatment strategy was suggested for 7 patients (14.8%) due to PET/CT results.

Conclusions:

• Combined PET/CT significantly enhances diagnostic accuracy in the initial work-up of lymphoma patients.
• PET/CT findings lead to stage modification and influence treatment planning.
• This integrated imaging approach improves the comprehensive management of lymphoma.